Literature DB >> 11913235

[Prognosis of retinoblastoma. Report of 50 cases].

H Bouguila1, I Malek, C Boujemâa, M Mouelhi, F Daghfous, L Nacef, S Ayed.   

Abstract

PURPOSE: The aim of this study was to analyze the factors influencing the prognosis of retinoblastoma.
MATERIALS AND METHODS: In 50 children with retinoblastoma, 69 eyes were reviewed. All patients had a full ophthalmic examination, a B-scan ultrasound, a computerized tomography scan and a pediatric examination. We performed enucleation in 47 eyes (with a histopathological study), external beam irradiation in 16 eyes, curitherapy in 4 eyes, cryotherapy in 3 eyes, and adjuvant chemotherapy in 7 cases.
RESULTS: The global survival rate was 87.5%. The main aggravating factors were: the size of the tumor and the extraretinal involvement with extension within the chroid, the sclera, and the optic nerve.
CONCLUSION: The prognosis of retinoblastoma mainly depends on the extraretinal invasion.

Entities:  

Mesh:

Year:  2001        PMID: 11913235

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN: 0181-5512            Impact factor:   0.818


  3 in total

1.  A multicentre report from the Mexican Retinoblastoma Group.

Authors:  C Leal-Leal; M Flores-Rojo; A Medina-Sansón; F Cerecedo-Díaz; S Sánchez-Félix; O González-Ramella; F Pérez-Pérez; R Gómez-Martínez; A Quero-Hernández; E Altamirano-Alvarez; F Alejo-González; J Figueroa-Carbajal; A Ellis-Irigoyen; I Tejocote-Romero; R Cervantes-Paz; F Pantoja-Guillén; L Vega-Vega; F Carrete-Ramírez
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

2.  Extra-ocular retinoblastoma: about 12 cases followed at the Mohamed VI university hospital of Marrakech.

Authors:  Soltani Leila; Hajji Ibtissam; Essafi Hafsa; Moutaouakil Abdeljalil
Journal:  Pan Afr Med J       Date:  2016-11-02

3.  Anatomo-Clinical Aspects of Retinoblastoma: A Series of 144 Cases.

Authors:  Fidélia Nihad Da Silva; Lafia Xavier Kora; Tania Elongo; Asmaa El Kebir; Loubna El Maaloum; Nisrine Bennani-Guebessi; Bouchra Allali; Asmaa El Kettani; Mehdi Karkouri
Journal:  Cureus       Date:  2022-05-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.